BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 22, 2006
View Archived Issues
Research Foundations of Orion and Farmos plan to merge
Read More
Laureate Pharma and Bradmer sign development and manufacturing agreement
Read More
p53 gene therapy feasible, active in esophageal carcinoma patients
Read More
Futility trial indicates creatine and minocycline deserve phase III investigation
Read More
Antihypertensives linked to reduced incidence of Alzheimer's disease
Read More
Antitumor and antiangiogenic validation of anti-S1P MAb from Lpath
Read More
Lilly and Biosite collaborate on biomarkers for Xigris therapy
Read More
Orphan drug designation for Zadaxin in malignant melanoma
Read More
Schering-Plough and PTC Therapeutics establish HCV collaboration
Read More
New phase II study for SNS-595 in small cell lung cancer
Read More
Medidur phase III trial recommended to continue
Read More
Preliminary 48-week from phase III psoriasis trial of ISA-247
Read More
Exelixis and Sankyo to develop novel therapies for cardiovascular disease
Read More
Phase II trial studying VRX-496 for HIV
Read More
NanoViricides achieves positive results in initial FluCide-I studies
Read More
POET-1 study of Altropane ended early for evaluation of data
Read More
NicOx and Merck to develop new antihypertensive drugs
Read More
Phase I/II study of obesity drug TM-30338 meets endpoints
Read More
Atorvastatin/glatiramer combination synergistic in multiple sclerosis model
Read More
LY-450139 investigated in Alzheimer's disease
Read More
RON: A novel target for anticancer therapy
Read More
OSI-930 reported safe in healthy volunteers
Read More
Thiovir active against H5N1 avian influenza chimeric virus strains
Read More
Elan completes sale of European Prialt rights to Eisai
Read More
Three new studies evaluate GEM OS1 in orthopedic indications
Read More
STRIDE study of I-vation Intravitreal Implant completes enrollment
Read More
Recent patents cover novel compounds for Alzheimer's and other neurological disorders
Read More
Therapeutic agents for gastrointestinal disorders disclosed in recent patent literature
Read More
Novel HIV vaccines jointly reported by Progenics and the Sloan-Kettering Institute
Read More